Suppr超能文献

[胶质瘤中转化生长因子-β1表达与调节性T细胞浸润的相关性]

[Correlation between TGF- β1 expression and Treg cell infiltration in glioma].

作者信息

Zhang Guan-hua, Jiang Xiao-bing, Zhang Xiang-heng, Sai Ke, Yang Qun-ying, Chen Zhong-ping, Mou Yong-gao

机构信息

Department of Neurosurgery, Cancer Center, State Key Laboratory of Oncology in South China, Sun Yat-sen University, Guangzhou 510060, China.

出版信息

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011 Jun;27(6):680-2.

Abstract

AIM

To investigate correlation between the expression of TGF-β1 and the amount of Treg cell in glioma, and evaluate their clinical values in predicting the prognosis of glioma.

METHODS

Double immunohistochemistry staining was used to detect the expression of TGF-β1, CD4 and Foxp3 in 135 specimens of human gliomas (WHO I 18, WHO II 45, WHO III 53, WHO IV 19) and 15 normal brain.

RESULTS

OF the 135 specimans of glioma, 58 showed low TGF-β1 expression and 77 (57.03%) showed high TGF-β1 expression while ws not expression in normal brain tissue. Average Treg cell density in glioma was 2. 031/HP, but there was no expression of Treg in normal brain tissue. Expression of TGF-β1 was positively correlated with the mount of Treg in glioma tissues (r = 0.294, P < 0.01). Compared with the low grade, The levels of TGF-β1 and the amount of Treg cells with significant higher in high-grade glioma, however the mount of Treg had no correlations with Sex, KPS score. The Laplan-Meier analysis showed that there wer significant difference in overall survival (OS) between the TGF-β1 high-expression and low-expression group (P < 0.001). Cox multivariate analysis showed that TGF-β1 and Treg were not independent prognostic factors (P > 0.05).

CONCLUSION

Intratumoral of TGF-β1 may relate to the infiltration of Treg cells in glioma tissues. The level of TGF-β1 was obviously increased in high grade. Glioma patients with TGF-β1 or Trg high expression have poorer prognosis, while TGF-β1 and Treg cannot serve as independent prognostic factors of glioma survival time.

摘要

目的

探讨转化生长因子-β1(TGF-β1)表达与胶质瘤中调节性T细胞(Treg细胞)数量的相关性,并评估其在预测胶质瘤预后中的临床价值。

方法

采用双重免疫组化染色法检测135例人脑胶质瘤标本(世界卫生组织(WHO)I级18例、WHO II级45例、WHO III级53例、WHO IV级19例)及15例正常脑组织中TGF-β1、CD4和叉头框蛋白3(Foxp3)的表达。

结果

135例胶质瘤标本中,58例TGF-β1表达低,77例(57.03%)TGF-β1表达高,正常脑组织中无表达。胶质瘤中Treg细胞平均密度为2.031/高倍视野(HP),正常脑组织中无Treg细胞表达。胶质瘤组织中TGF-β1表达与Treg细胞数量呈正相关(r = 0.294,P < 0.01)。与低级别胶质瘤相比,高级别胶质瘤中TGF-β1水平及Treg细胞数量显著更高,然而Treg细胞数量与性别、卡氏评分(KPS)无关。寿命表分析显示,TGF-β1高表达组与低表达组的总生存期(OS)有显著差异(P < 0.001)。Cox多因素分析显示,TGF-β1和Treg不是独立的预后因素(P > 0.05)。

结论

胶质瘤组织中TGF-β1可能与Treg细胞浸润有关。高级别胶质瘤中TGF-β1水平明显升高。TGF-β1或Treg高表达的胶质瘤患者预后较差,而TGF-β1和Treg不能作为胶质瘤生存时间的独立预后因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验